Mayawala, Kapil

Model-based analysis of the relationship between pembrolizumab (MK-3475) exposure and efficacy in patients with advanced or metastatic melanoma.

Gangadhar, Tara C., Hamid, Omid , Dummer, Reinhard , Mehnert, Janice M. , Celentano, Kellie Ann, Lindia, Jill A., Chatterjee, Manash , Turner, David C. , Mayawala, Kapil , Elassaiss‐Schaap, Jeroen , Alwis, Dinesh P. de, Li, Xiaoyun , Ebbinghaus, Scot, Kang, Soonmo Peter, Kefford, Richard , Joseph, Richard W. , Puzanov, Igor , Robert, Caroline , Ribas, Antoni , Daud, Adil

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3068-3068

10.1200/jco.2015.33.15_suppl.3068